Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere-...
58
Diagnóstico, biomonitoreo Y pronóstico
Transcript of Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere-...
![Page 1: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/1.jpg)
Diagnóstico, biomonitoreo Y pronóstico
![Page 2: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/2.jpg)
![Page 3: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/3.jpg)
![Page 4: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/4.jpg)
![Page 5: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/5.jpg)
![Page 6: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/6.jpg)
![Page 7: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/7.jpg)
![Page 8: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/8.jpg)
![Page 9: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/9.jpg)
![Page 10: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/10.jpg)
![Page 11: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/11.jpg)
![Page 12: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/12.jpg)
![Page 13: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/13.jpg)
![Page 14: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/14.jpg)
![Page 15: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/15.jpg)
![Page 16: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/16.jpg)
![Page 17: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/17.jpg)
![Page 18: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/18.jpg)
EBV
KSHV
HBV
HCV
PAPILOMAVIRUS
ADENOVIRUS
![Page 19: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/19.jpg)
LINFOMA DE BURKITT MALIGNO –Virus de epstein barr (ebv)
![Page 20: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/20.jpg)
![Page 21: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/21.jpg)
![Page 22: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/22.jpg)
Cancer de hígado –Virus de hepatitis b Y hepatitis c
![Page 23: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/23.jpg)
![Page 24: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/24.jpg)
![Page 25: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/25.jpg)
![Page 26: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/26.jpg)
![Page 27: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/27.jpg)
![Page 28: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/28.jpg)
![Page 29: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/29.jpg)
Cancer de cuello uterino –Virus del papiloma humano ( hpv)
![Page 30: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/30.jpg)
![Page 31: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/31.jpg)
![Page 32: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/32.jpg)
Sarcoma de kaposi–Virus de inmunodeficiencia humana(
hiv)
![Page 33: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/33.jpg)
![Page 34: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/34.jpg)
![Page 35: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/35.jpg)
![Page 36: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/36.jpg)
![Page 37: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/37.jpg)
![Page 38: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/38.jpg)
![Page 39: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/39.jpg)
![Page 40: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/40.jpg)
ADEnocarcinoma colorectal
![Page 41: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/41.jpg)
![Page 42: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/42.jpg)
![Page 43: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/43.jpg)
LINFOMA DE BURKITT
![Page 44: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/44.jpg)
![Page 45: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/45.jpg)
LEUCEMIA MIELOGÉNICA CRÓNICAoncogen abl
![Page 46: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/46.jpg)
![Page 47: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/47.jpg)
retinoblastomagen Rb –
Locus 13q14
![Page 48: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/48.jpg)
![Page 49: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/49.jpg)
![Page 50: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/50.jpg)
DIAGNÓSTICO, BIOMONITOREO Y PRONÓSTICO EN TRUJILLO
![Page 51: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/51.jpg)
![Page 52: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/52.jpg)
![Page 53: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/53.jpg)
![Page 54: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/54.jpg)
![Page 55: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/55.jpg)
![Page 56: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/56.jpg)
![Page 57: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/57.jpg)
![Page 58: Diagnóstico, biomonitoreo Y pronóstico · 22.430 (3%) 19.600 (3%) 19.440 (3%) ... (p. ej., cere- bral, leucemia, mama, ... NF-2(neurofibromatosis tipo 2) DCC ...](https://reader030.fdocumento.com/reader030/viewer/2022020114/5b96b13709d3f2501c8b8107/html5/thumbnails/58.jpg)